Imaging the Neuroimmune System in PTSD
Imaging the Neuroimmune System in PTSD With PET
Sponsor: National Institute of Mental Health (NIMH)
Listed as NCT04236986, this PHASE1 trial focuses on Post Traumatic Stress Disorder and remains completed. Sponsored by National Institute of Mental Health (NIMH), it has been updated 12 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Jan 2025 — Present [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
Oct 2024 — Jan 2025 [monthly]
Active Not Recruiting PHASE1
-
Sep 2024 — Oct 2024 [monthly]
Active Not Recruiting PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE1
-
Nov 2023 — Jul 2024 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
▶ Show 7 earlier versions
-
Jul 2023 — Nov 2023 [monthly]
Recruiting PHASE1
-
Jan 2023 — Jul 2023 [monthly]
Recruiting PHASE1
-
Jun 2022 — Jan 2023 [monthly]
Recruiting PHASE1
-
May 2022 — Jun 2022 [monthly]
Recruiting PHASE1
-
May 2021 — May 2022 [monthly]
Recruiting PHASE1
-
Jan 2021 — May 2021 [monthly]
Recruiting PHASE1
-
Feb 2020 — Jan 2021 [monthly]
Recruiting PHASE1
First recorded
Mar 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Mental Health (NIMH)
- Yale University
For direct contact, visit the study record on ClinicalTrials.gov .